Yingjian Medical: It is estimated that the owner of the 2022 fiscal will take advantage of the profit of no less than 350 million Hong Kong dollars

On September 15, 2022, Yingjian Medical (Code: 01419.HK), a Hong Kong stock market company, released the 2022 annual annual report performance preview. As of June 30, 2022, the performance increased sharply, and it was expected to record no less than 350 million The Hong Kong dollar company owner should take advantage of the profit, compared to the company's owners 'accounting for about 145 million Hong Kong dollars for the company's owners' owners at the end of June 30, 2012. The company's industry is medical technology.

The company made the above predictions based on the following reasons: (i) the income of general medical services increased, which is due to the continuous increase in demand for prevention, testing, vaccination, and exterior services; ) The increase in tax revenue of courses caused by the increase in income tax expenses.

Yingjian Medical Group Co., Ltd. is a Hong Kong private comprehensive medical service provider, which has a comprehensive outpatient capabilities covering general medical services, specialized medical services and dental services. All medical services include medical services related to family medicine, such as general consulting, diagnosis and preventive medical services, treatment services, small surgery, drug deployment, vaccination, physical examination, health education activities, and providing occupational health consultation and work injury Evaluation, etc. Specialty medical services include general surgery, plastic surgery and trauma, ophthalmology, otolaryngology, pediatric surgery, obstetrics and gynecology, cardiology, gastrointestinal and liver specialties, respiratory and dermatology, etc. Dental services include ordinary dental, specialist dental dental dental dentistry.

- END -